[144] Tesla, Inc. SEC Filing

Rhea-AI Filing Summary

Tesla, Inc. (TSLA) Form 144 notice: An insider plans to sell 60,000 common shares through J.P. Morgan Securities LLC with an approximate aggregate market value of $23,756,400. The sale is scheduled for 09/15/2025. The shares were acquired on 06/03/2024 via an option exercise and paid in cash. The issuer reports 3,225,448,889 shares outstanding. The filing also discloses a prior sale on 08/26/2025 of 120,000 shares by JRM Revocable Trust for $42,034,358.88. The filer certifies no undisclosed material adverse information and includes the required signature representation.

Positive

• Full procedural disclosure of the planned sale including broker, acquisition method, and dates
• Securities were acquired via option exercise and paid in cash, which clarifies the source of the shares
• Prior sale within three months disclosed, improving transparency about recent insider activity

Negative

• Insider selling activity: proposed sale of 60,000 shares (~$23.8M) and a recent 120,000-share sale could be viewed negatively by some investors
• Material context limited to transaction details; the filing does not provide reasons for the sales beyond routine representations

Insights

Securities Analyst

TL;DR: Insider liquidity event of modest scale relative to shares outstanding; transparent Form 144 disclosure.

The filing notifies the market of a proposed sale of 60,000 shares valued at roughly $23.8 million executed through a registered broker. The shares were acquired via option exercise and paid in cash, indicating the sale is likely for liquidity rather than receipt of new equity. Compared with the company's 3.225 billion shares outstanding, this block is small in percentage terms. The disclosure of a recent 120,000-share sale by an affiliated trust provides additional context on recent insider selling activity.

Corporate Governance Expert

TL;DR: Form 144 is procedurally compliant and includes the standard insider representation.

The notice includes required transaction details: acquisition date, nature (option exercise), broker identity, planned sale date, and prior three-month sale. The filer affirms there is no undisclosed material adverse information and signs the attestation, meeting Rule 144 procedural expectations. From a governance perspective, the filing enhances transparency around insider dispositions without introducing new governance issues in the document itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 390 Madison Avenue - 6th Floor New York NY 10017	60000	23756400	3225448889	09/15/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/03/2024	Option Exercise	Issuer			60000	06/03/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JRM Revocable Trust Care of Tesla Inc 1 Tesla Road Austin TX 78725	Common	08/26/2025	120000	42034358.88

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Tesla (TSLA) Form 144 disclose about the proposed sale?

The form discloses a proposed sale of 60,000 common shares through J.P. Morgan Securities LLC with an aggregate market value of $23,756,400, scheduled for 09/15/2025.

How were the 60,000 TSLA shares acquired?

The shares were acquired on 06/03/2024 via an option exercise and payment was made in cash.

Does the filing report any recent sales of TSLA shares by related parties?

Yes. The filing shows a sale on 08/26/2025 of 120,000 shares by JRM Revocable Trust for $42,034,358.88.

How many TSLA shares are outstanding according to the form?

The filing reports 3,225,448,889 shares outstanding.

Does the filer state there is undisclosed material information?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.